Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real-world study.
Cerulli Irelli E, Mazzeo A, Caraballo RH, Perulli M, Moloney PB, Peña-Ceballos J, Rubino M, Mieszczanek KM, Santangelo A, Licchetta L, De Giorgis V, Reyes Valenzuela G, Casellato S, Cesaroni E, Operto FF, Domínguez-Carral J, Ramírez-Camacho A, Ferretti A, Santangelo G, Aledo-Serrano A, Rüegger A, Mancardi MM, Prato G, Riva A, Bergonzini L, Cordelli DM, Bonanni P, Bisulli F, Di Gennaro G, Matricardi S, Striano P, Delanty N, Marini C, Battaglia D, Di Bonaventura C, Ramantani G, Gardella E; GENE‐CBD Study Group; Orsini A, Coppola A.
Cerulli Irelli E, et al. Among authors: casellato s.
Epilepsia. 2025 Mar 24. doi: 10.1111/epi.18378. Online ahead of print.
Epilepsia. 2025.
PMID: 40126049